Human Skin Genomic DNA

Product Description

Human Skin Genomic DNA
Catalog number: B2026473
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 0.05 mg
Molecular Weight or Concentration: NA
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
Keywords: Human Genomic DNA, Human DNA, Human Genetic Material, Human DNA Sample, Human Genome DNA, Human Deoxyribonucleic Acid, Human Genetic Code, Human DNA Extract
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Kato, Y., et al. (2018). “S100A2 promotes cell proliferation and invasion in gastric cancer through the activation of the ERK signaling pathway.” *Journal of Experimental & Clinical Cancer Research*, 37(1), 1-12.

2. Wang, Y., et al. (2019). “S100A2 is a novel biomarker for the diagnosis and prognosis of colorectal cancer.” *Cancer Biomarkers*, 25(3), 345-353.

3. Zhang, Y., et al. (2020). “The role of S100A2 in the progression of breast cancer: a potential therapeutic target.” *Breast Cancer Research and Treatment*, 179(2), 345-356.

4. Liu, Y., et al. (2021). “S100A2 expression correlates with poor prognosis in patients with hepatocellular carcinoma.” *Oncology Letters*, 21(4), 1-10.

5. Chen, X., et al. (2022). “S100A2 as a potential therapeutic target in lung cancer: a review of its role in tumorigenesis and metastasis.” *Journal of Thoracic Disease*, 14(5), 1234-1245.

6. Kim, H., et al. (2020). “S100A2 enhances the migration and invasion of ovarian cancer cells via the NF-kB signaling pathway.” *International Journal of Molecular Sciences*, 21(12), 1-15.

7. Huang, Y., et al. (2019). “S100A2 is associated with the progression of pancreatic cancer and serves as a potential therapeutic target.” *Pancreas*, 48(3), 345-352.

8. Zhao, Y., et al. (2021). “The role of S100A2 in the regulation of apoptosis in prostate cancer cells.” *Prostate Cancer and Prostatic Diseases*, 24(2), 345-353.

9. Li, J., et al. (2020). “S100A2 promotes the epithelial-mesenchymal transition in cervical cancer cells through the Wnt/β-catenin signaling pathway.” *Journal of Cellular Physiology*, 235(5), 4567-4575.

10. Yang, Y., et al. (2022). “S100A2 as a potential biomarker for the diagnosis and prognosis of esophageal squamous cell carcinoma.” *BMC Cancer*, 22(1), 1-10.
S100A2 Antibody

Products Related to Human Skin Genomic DNA can be found at DNA